Lv4
540 积分 2023-03-14 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer
1个月前
已完结
Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms
1个月前
已完结
Pancreatic cancer
1个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy
5个月前
已完结
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
5个月前
已完结
Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells
7个月前
已关闭
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
7个月前
已完结
Probiotic-guided CAR-T cells for solid tumor targeting
1年前
已完结
皖公网安备34019202002308
